Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

KW-2449 safe and well tolerated in phase I study in hematologic malignancies

Dec. 14, 2007

Weight loss seen with taranabant in obese subjects

Dec. 14, 2007

Plasmid-mediated delivery of IGF-1 gene useful in mouse model of ALS

Dec. 14, 2007

Zevalin meets primary endpoint in follicular non-Hodgkin's lymphoma trial

Dec. 14, 2007

Pooled trial data confirm eculizumab efficacy in paroxysmal nocturnal hemoglobinuria

Dec. 13, 2007

Rivaroxaban thromboprophylaxis effective after hip replacement surgery

Dec. 13, 2007

Preclinical studies of anti-DKK1 mAb show potential for multiple myeloma therapy

Dec. 13, 2007

New preclinical and clinical data detail antithrombotic effects of YM-150

Dec. 13, 2007

Carfilzomib well tolerated in consecutive-day schedule in hematologic malignancies

Dec. 13, 2007

Neurotrophic-expressing AAV vectors improve symptoms in mouse model of ALS

Dec. 12, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...